Last quarter (Q3 2024), Sonoma Pharmaceuticals's total revenue was $3.14M, an increase of 6.59% from the same quarter last year. In Q3, Sonoma Pharmaceuticals's net income was $-866.00K. See Sonoma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	$ 12.31M	$ 13.27M	$ 12.63M	$ 18.63M	$ 17.93M	$ 18.97M
Cost of Revenue	$ 21.08M	$ 8.79M	$ 8.63M	$ 12.07M	$ 9.81M	$ 10.09M
Gross Profit	$ 4.52M	$ 4.48M	$ 3.99M	$ 6.56M	$ 8.12M	$ 8.88M
Operating Expense	$ 23.87M	$ 9.05M	$ 10.27M	$ 10.01M	$ 15.51M	$ 20.14M
Operating Income	$ -4.96M	$ -4.57M	$ -6.28M	$ -3.45M	$ -7.39M	$ -11.26M
Net Non Operating Interest Income Expense	$ 16.00K	$ 16.00K	$ -10.00K	$ 4.00K	$ 34.00K	$ 157.00K
Other Income Expense	$ 723.00K	$ -1.00K	$ -873.00K	$ -457.00K	$ 3.81M	$ -239.00K
Pretax Income	$ -5.11M	$ -5.18M	$ -5.42M	$ -3.90M	$ -3.54M	$ -11.34M
Tax Provision	$ -36.00K	$ -33.00K	$ -332.00K	$ 713.00K	$ 29.00K	$ 458.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -5.08M	$ -5.15M	$ -5.09M	$ -3.95M	$ -3.31M	$ -11.80M
Basic EPS	$ -0.94	$ -1.52	$ -1.92	$ -1.97	$ -1.99	$ -12.77
Diluted EPS	$ -0.94	$ -1.52	$ -1.92	$ -1.97	$ -1.99	$ -12.77
Basic Average Shares	$ 10.92M	$ 3.39K	$ 2.65K	$ 2.00M	$ 1.48M	$ 924.00K
Diluted Average Shares	$ 10.92M	$ 3.39K	$ 2.65K	$ 2.00M	$ 1.48M	$ 924.00K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 44.95M	$ 17.84M	$ 18.91M	$ 22.08M	$ 25.32M	$ 30.23M
Net Income From Continuing And Discontinued Operation	$ -5.08M	$ -5.15M	$ -5.09M	$ -3.95M	$ -3.31M	$ -11.80M
Normalized Income	$ -3.75M	$ -4.36M	-	$ -4.72M	$ -6.18M	$ -11.80M
Interest Expense	-	-	-	$ 12.00K	$ 16.00K	$ 33.00K
EBIT	$ -5.12M	$ -5.20M	$ -5.41M	$ -3.89M	$ -3.53M	$ -11.31M
EBITDA	$ -4.96M	$ -5.08M	$ -5.22M	$ -3.66M	$ -3.22M	$ -10.85M

Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing